Detalhe da pesquisa
1.
Assessment of Human Epineural Conduit of Different Size Diameters on Efficacy of Nerve Regeneration and Functional Outcomes.
J Reconstr Microsurg
; 39(5): 392-404, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379456
2.
Efficacy of Engraftment and Safety of Human Umbilical Di-Chimeric Cell (HUDC) Therapy after Systemic Intraosseous Administration in an Experimental Model.
Biomedicines
; 12(5)2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791026
3.
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model.
Biomedicines
; 12(3)2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38540201
4.
Human Multi-Chimeric Cell (HMCC) Therapy as a Novel Approach for Tolerance Induction in Transplantation.
Stem Cell Rev Rep
; 19(8): 2741-2755, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603137
5.
Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression.
Stem Cell Investig
; 10: 16, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614644
6.
Creation of human hematopoietic chimeric cell (HHCC) line as a novel strategy for tolerance induction in transplantation.
Stem Cell Investig
; 9: 11, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36619595
7.
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Stem Cell Rev Rep
; 18(8): 2872-2892, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35590083
8.
Optimization of human myoblasts culture under different media conditions for application in the in vitro studies.
Am J Stem Cells
; 11(1): 1-11, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35295592
9.
Application of Human Epineural Conduit Supported with Human Mesenchymal Stem Cells as a Novel Therapy for Enhancement of Nerve Gap Regeneration.
Stem Cell Rev Rep
; 18(2): 642-659, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34787795
10.
Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.
Arch Immunol Ther Exp (Warsz)
; 70(1): 20, 2022 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35978142
11.
Correction: Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Stem Cell Rev Rep
; 19(2): 582-583, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441490